{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:04:48Z","timestamp":1784822688545,"version":"3.55.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:00:00Z","timestamp":1780790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Secondary Restless Legs Syndrome (RLS) has repeatedly been associated with psychopharmacotherapy, especially antidepressants and antipsychotics. However, existing evidence is conflicting in terms of the magnitude of the association as well as the significance of substance classes or individual compounds. The objective of the present study was to evaluate secondary RLS linked to psychotropic medication in real-world, inpatient clinical routine treatment settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A large dataset from a multinational pharmacovigilance program in German-speaking countries (Arzneimittelsicherheit in der Psychiatrie, \u201cDrug safety in Psychiatry\u201d) from January 2001 to December 2016 was retrospectively analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In a total of 340\u2009099 monitored inpatients, 67 cases of newly diagnosed and severe RLS related to psychotropic drug treatment were recorded equivalent to a relative frequency of 0.02%. Over 80% of the cases were attributable to two compounds: the antidepressant mirtazapine and the antipsychotic quetiapine. Mirtazapine was found in 39 patients, while quetiapine was found in 16 patients with secondary RLS. For both substances, drug dosages were generally low at onset of secondary RLS. Most cases exhibited an onset within 1 or 2\u00a0days after dosage start or change.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Histamine neurotransmission may represent a crucial common denominator in terms of secondary RLS in association with psychopharmacotherapeutics, as both substances exhibit antihistamingeric effects at lower dosages.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ijnp\/pyag029","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T11:42:41Z","timestamp":1780659761000},"source":"Crossref","is-referenced-by-count":0,"title":["Secondary Restless Legs Syndrome during psychopharmacological treatment: real-world evidence from a multinational pharmacovigilance program"],"prefix":"10.1093","volume":"29","author":[{"given":"Gernot","family":"Fugger","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Psychotherapeutic Medicine, University Hospital St. P\u00f6lten, Karl Landsteiner Private University of Health Sciences , Krems an der Donau ,","place":["Austria"]},{"name":"Department of Psychiatry and Psychotherapy, Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Rabl","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapeutic Medicine, University Hospital St. P\u00f6lten, Karl Landsteiner Private University of Health Sciences , Krems an der Donau ,","place":["Austria"]},{"name":"Department of Psychiatry and Psychotherapy, Medical University of Vienna , Vienna ,","place":["Austria"]},{"name":"Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Bartova","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Medical University of Vienna , Vienna ,","place":["Austria"]},{"name":"Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Popper","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Medical University of Vienna , Vienna ,","place":["Austria"]},{"name":"Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Watzal","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Medical University of Vienna , Vienna ,","place":["Austria"]},{"name":"Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Ivkic","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Medical University of Vienna , Vienna ,","place":["Austria"]},{"name":"Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Donath","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Medical University of Vienna , Vienna ,","place":["Austria"]},{"name":"Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3367-9221","authenticated-orcid":false,"given":"Constance","family":"Busvine","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapeutic Medicine, University Hospital St. P\u00f6lten, Karl Landsteiner Private University of Health Sciences , Krems an der Donau ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldemar","family":"Greil","sequence":"additional","affiliation":[{"name":"Psychiatric Private Hospital, Sanatorium Kilchberg , Zurich ,","place":["Switzerland"]},{"name":"Department of Psychiatry and Psychotherapy, LMU University Hospital , Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sermin","family":"Toto","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School , Hannover ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"Grohmann","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, LMU University Hospital , Munich ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Frey","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Medical University of Vienna , Vienna ,","place":["Austria"]},{"name":"Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Konstantinidis","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Medical University of Vienna , Vienna ,","place":["Austria"]},{"name":"BBRZMed Simmering, Center for Mental Health , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Erfurth","sequence":"additional","affiliation":[{"name":"1st Department of Psychiatry and Psychotherapeutic Medicine, Hietzing Hospital , Vienna ,","place":["Austria"]},{"name":"Karl Landsteiner Institute for Clinical Risk Management , Karl Landsteiner Society, Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8278-191X","authenticated-orcid":false,"given":"Siegfried","family":"Kasper","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Medical University of Vienna , Vienna ,","place":["Austria"]},{"name":"Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna , Vienna ,","place":["Austria"]},{"name":"Center for Brain Research, Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,7]]},"reference":[{"key":"2026072311162247900_ref1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.sleep.2014.03.025","article-title":"Restless legs syndrome\/Willis-Ekbom disease diagnostic criteria: updated international restless legs syndrome study group (IRLSSG) consensus criteria\u2014history, rationale, description, and significance","volume":"15","author":"Allen","year":"2014","journal-title":"Sleep Med"},{"key":"2026072311162247900_ref2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.sleep.2016.06.007","article-title":"Achievements, challe,nges, and future perspectives of epidemiologic research in restless legs syndrome (RLS)","volume":"31","author":"Picchietti","year":"2017","journal-title":"Sleep Med"},{"key":"2026072311162247900_ref3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41572-021-00311-z","article-title":"Restless legs syndrome","volume":"7","author":"Manconi","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2026072311162247900_ref4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jsmc.2015.05.021","article-title":"Differential diagnoses of restless legs syndrome\/Willis-Ekbom disease: mimics and comorbidities","volume":"10","author":"Chokroverty","year":"2015","journal-title":"Sleep Med Clin"},{"key":"2026072311162247900_ref5","doi-asserted-by":"publisher","first-page":"e679","DOI":"10.4088\/JCP.13r08692","article-title":"Mood disorders in restless legs syndrome (Willis-Ekbom disease)","volume":"75","author":"Becker","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"2026072311162247900_ref6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.smrv.2017.06.002","article-title":"The influence of antidepressants on restless legs syndrome and periodic limb movements: a systematic review","volume":"38","author":"Kolla","year":"2018","journal-title":"Sleep Med Rev"},{"key":"2026072311162247900_ref7","doi-asserted-by":"publisher","first-page":"105126","DOI":"10.1016\/j.neubiorev.2023.105126","article-title":"Periodic leg movements during sleep associated with antidepressants: a meta-analysis","volume":"148","author":"Ferri","year":"2023","journal-title":"Neurosci Biobehav Rev"},{"key":"2026072311162247900_ref8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00406-013-0419-y","article-title":"Flupentixol use and adverse reactions in comparison with other common first- and second-generation antipsychotics: data from the AMSP study","volume":"264","author":"Grohmann","year":"2014","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2026072311162247900_ref9","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1055\/s-2004-815505","article-title":"The AMSP drug safety program: methods and global results","volume":"37 Suppl 1","author":"Grohmann","year":"2004","journal-title":"Pharmacopsychiatry."},{"key":"2026072311162247900_ref10","doi-asserted-by":"publisher","first-page":"pyv126","DOI":"10.1093\/ijnp\/pyv126","article-title":"Drug-induced liver injury during antidepressant treatment: results of AMSP, a drug surveillance program","volume":"19","author":"Friedrich","year":"2016","journal-title":"Int J Neuropsychopharmacol"},{"key":"2026072311162247900_ref11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/s1389-9457(03)00010-8","article-title":"Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health","volume":"4","author":"Allen","year":"2003","journal-title":"Sleep Med"},{"key":"2026072311162247900_ref12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1055\/s-2007-1007282","article-title":"Epidemiological identification and evaluation of hepatic adverse drug reactions","volume":"15","author":"Bruppacher","year":"1995","journal-title":"Semin Liver Dis"},{"key":"2026072311162247900_ref13","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1016\/j.euroneuro.2015.08.019","article-title":"A review of the current nomenclature for psychotropic agents and an introduction to the neuroscience-based nomenclature","volume":"25","author":"Zohar","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"2026072311162247900_ref14","doi-asserted-by":"publisher","first-page":"e27821","DOI":"10.7759\/cureus.27821","article-title":"Restless legs syndrome and the use of antipsychotic medication: an updated literature review","volume":"14","author":"Saber","year":"2022","journal-title":"Cureus."},{"key":"2026072311162247900_ref15","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1177\/1060028018760296","article-title":"Drug-induced restless legs syndrome","volume":"52","author":"Patatanian","year":"2018","journal-title":"Ann Pharmacother"},{"key":"2026072311162247900_ref16","doi-asserted-by":"publisher","first-page":"811","DOI":"10.5664\/jcsm.10440","article-title":"Pharmacological responsiveness of periodic limb movements in patients with restless legs syndrome: a systematic review and meta-analysis","volume":"19","author":"Riccardi","year":"2023","journal-title":"J Clin Sleep Med"},{"key":"2026072311162247900_ref17","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00228-020-02847-7","article-title":"Selective serotonin reuptake inhibitors and the risk of restless legs syndrome: a symmetry analysis","volume":"76","author":"Dunvald","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"key":"2026072311162247900_ref18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.5152\/pcp.2022.21307","article-title":"Restless legs syndrome: associated with major depressive disorder and anxiety disorder but not with antidepressant use","volume":"32","author":"Yilbas","year":"2022","journal-title":"Psychiatry Clin Psychopharmacol"},{"key":"2026072311162247900_ref19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2165\/11317500-000000000-00000","article-title":"Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management","volume":"24","author":"Hornyak","year":"2010","journal-title":"CNS Drugs"},{"key":"2026072311162247900_ref20","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/JCP.0b013e318272cdd8","article-title":"Drugs associated with restless legs syndrome: a case\/noncase study in the French Pharmacovigilance Database","volume":"32","author":"Perez-Lloret","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"2026072311162247900_ref21","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12888-020-02711-z","article-title":"Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database","volume":"20","author":"Revet","year":"2020","journal-title":"BMC Psychiatry"},{"key":"2026072311162247900_ref22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5334\/tohm.739","article-title":"A narrative review of the lesser known medications for treatment of restless legs syndrome and pathogenetic implications for their use","volume":"13","author":"Yeh","year":"2023","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"2026072311162247900_ref23","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1017\/s1461145712001599","article-title":"Restless legs syndrome induced by quetiapine: report of seven cases and review of the literature","volume":"16","author":"Rittmannsberger","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"2026072311162247900_ref24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.euroneuro.2022.11.008","article-title":"Effects of quetiapine on sleep: a systematic review and meta-analysis of clinical trials","volume":"67","author":"Lin","year":"2023","journal-title":"Eur Neuropsychopharmacol"},{"key":"2026072311162247900_ref25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/da.20017","article-title":"Quetiapine is effective against anxiety and depressive symptoms in long-term treatment of patients with schizophrenia","volume":"20","author":"Kasper","year":"2004","journal-title":"Depress Anxiety"},{"key":"2026072311162247900_ref26","doi-asserted-by":"publisher","DOI":"10.1017\/9781108975292","volume-title":"Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications","author":"Stahl","year":"2021","edition":"5"},{"key":"2026072311162247900_ref27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/s0924-977x(96)00394-x","article-title":"Pharmacological treatment of severely depressed patients: a meta-analysis comparing efficacy of mirtazapine and amitriptyline","volume":"7","author":"Kasper","year":"1997","journal-title":"Eur Neuropsychopharmacol"},{"key":"2026072311162247900_ref28","doi-asserted-by":"publisher","first-page":"929","DOI":"10.2147\/nss.S513538","article-title":"Exploring the top 50 drugs associated with restless legs syndrome based on the FDA data from 2004 to 2024","volume":"17","author":"Wei","year":"2025","journal-title":"Nat Sci Sleep"},{"key":"2026072311162247900_ref29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.euroneuro.2023.03.015","article-title":"Antipsychotic-induced akathisia in adults with acute schizophrenia: a systematic review and dose-response meta-analysis","volume":"72","author":"Wu","year":"2023","journal-title":"Eur Neuropsychopharmacol"},{"key":"2026072311162247900_ref30","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1017\/s1461145713001417","article-title":"5-HT2A receptor antagonists for the treatment of neuroleptic-induced akathisia: a systematic review and meta-analysis","volume":"17","author":"Laoutidis","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"2026072311162247900_ref31","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s40264-023-01302-7","article-title":"Factors associated with underreporting of adverse drug reactions by health care professionals: a systematic review update","volume":"46","author":"Garcia-Abeijon","year":"2023","journal-title":"Drug Saf"},{"key":"2026072311162247900_ref32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1600-0447.2008.01211.x","article-title":"\u2018Diagnostic overshadowing\u2019: worse physical health care for people with mental illness","volume":"118","author":"Jones","year":"2008","journal-title":"Acta Psychiatr Scand"}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ijnp\/advance-article-pdf\/doi\/10.1093\/ijnp\/pyag029\/68485210\/pyag029.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijnp\/article-pdf\/29\/7\/pyag029\/68485210\/pyag029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijnp\/article-pdf\/29\/7\/pyag029\/68485210\/pyag029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:16:31Z","timestamp":1784819791000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article\/doi\/10.1093\/ijnp\/pyag029\/8703484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ijnp\/pyag029","relation":{},"ISSN":["1461-1457","1469-5111"],"issn-type":[{"value":"1461-1457","type":"print"},{"value":"1469-5111","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,6,7]]},"article-number":"pyag029"}}